Sofosbuvir/daclatasvir combination could be produced for $200 per hepatitis C cure
WHO issues recommendations on linkage to care, retention, to help bring HIV treatment to all
Almost half of US Medicaid recipients denied funding for hepatitis C treatment, 4-state study shows
With EACS release, all international HIV treatment guidelines agree on when to start – for the first time since 2006
Newest MDR-TB drug prices could fall by up to 95% through generic production
How do we treat the world? Experts discuss moving to universal HIV treatment
At least 25,000 people in the US may now be using PrEP
Affordable Care Act coverage improves chances of viral suppression for Americans with HIV
WHO guidelines recommend universal antiretroviral treatment, PrEP for those at substantial risk
